Abstract:Key Points A large fraction of point mutations that cause genetic diseases affect splicing efficiency and/or accuracy. Most of these mutations directly affect the canonical consensus sequences that define exon–intron boundaries, and are therefore correctly identified as 'splicing mutations'. Information that is present in the coding regions of genes also contributes to the correct identification of exon–intron boundaries. For example, exonic splicing enhancer (ESE) and silencer (ESS) elements are very prevalent and might be present in most, if not all, constitutive and alternative exons. ESEs are recognized by a class of splicing factors, the SR proteins, that promote splicing by recruiting spliceosomal components to the correct splice sites and/or by antagonizing the action of nearby silencers. Several classes of ESEs, which are recognized by different SR proteins, have been identified, and computational tools are being developed to predict the location, specificity and efficiency of putative ESEs. Because ESEs are embedded in protein-coding sequences, some nonsense, missense and translationally silent point mutations have actually been misclassified. Those mutations that inactivate an ESE can result in partial or complete exon skipping, and can therefore markedly affect the structure or amounts of the expressed protein product. An increasing proportion of point mutations are being reported to affect pre-mRNA splicing. Although reading-frame-dependent mechanisms have been proposed to account for nonsense-associated altered splicing (NAS), in most cases the disruption of ESEs or of RNA secondary structures that are required for proper splicing seems to be the mechanism that leads to exon skipping, regardless of the type of point mutation. Some coding single-nucleotide polymorphisms (cSNPs) can be expected likewise to disrupt elements that are involved in splicing and to exert a subtle effect on splice-site selection, thereby contributing to phenotypic variability, to the variable penetrance of mutations elsewhere in the gene and to cell-type-specific differences in gene expression. The effects of point mutations should be routinely analysed at the mRNA level before drawing conclusions about the importance of the affected amino acid, as their correct classification in terms of the actual mechanism of gene inactivation is essential for understanding structure–function relationships in the corresponding protein, for assessing the phenotypic risk in individuals with familial disease predispositions and for devising new therapies.

Skipping of an Exon with a Nonsense Mutation in the DMD Gene is Induced by the Conversion of a Splicing Enhancer to a Splicing Silencer.

A splicing silencer in SMN2 intron 6 is critical in spinal muscular atrophy

Splicing Characteristics of Dystrophin Pseudoexons and Identification of a Novel Pathogenic Intronic Variant in the <i>DMD</i> Gene

Three novel splicing mutations at 5' terminal of DMD gene corresponding to different phenotypes

Splicing Characteristics of Dystrophin Pseudoexons and Identification of a Novel Pathogenic Intronic Variant in the DMD Gene

Listening to silence and understanding nonsense: exonic mutations that affect splicing

Functional Analysis of Variants in DMD Exon/intron 10 Predicted to Affect Splicing

HNRNPA1-induced spliceopathy in a transgenic mouse model of myotonic dystrophy.

Synonymous Variant at the Terminal Nucleotide in Exon 3 of F7 Causes Abnormal Splicing: A Case Report

Dual Mechanism of a New SMN1 Variant (c.835G>C, p.Gly279Arg) by Interrupting Exon 7 Skipping and YG Oligomerization in Causation of Spinal Muscular Atrophy

Intron-targeted mutagenesis reveals roles for<i>Dscam1</i>RNA pairing-mediated splicing bias in neuronal wiring

Regulation of Dscam Exon 17 Alternative Splicing by Steric Hindrance in Combination with RNA Secondary Structures.

Intron-targeted mutagenesis reveals roles for <i>Dscam1</i> RNA pairing architecture-driven splicing bias in neuronal wiring

A new pseudoexon activation due to ultrarare branch point formation in Duchenne muscular dystrophy

HnRNPR strongly represses splicing of a critical exon associated with spinal muscular atrophy through binding to an exonic AU-rich element

Defective Minor Spliceosomes Induce SMA-associated Phenotypes Through Sensitive Intron-Containing Neural Genes in Drosophila

Hnrnp A1 Functions with Specificity in Repression of Smn2 Exon 7 Splicing

A disease-causing intronic point mutation C19G alters tau exon 10 splicing via RNA secondary structure rearrangement.

Inhibition of SF3B1 by Molecules Targeting the Spliceosome Results in Massive Aberrant Exon Skipping

The exon junction complex is required for DMD gene splicing fidelity and myogenic differentiation

Splicing inhibition of U2AF65 leads to alternative exon skipping